Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

149 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer.
Bracci L, Schiavoni G, Sistigu A, Belardelli F. Bracci L, et al. Cell Death Differ. 2014 Jan;21(1):15-25. doi: 10.1038/cdd.2013.67. Epub 2013 Jun 21. Cell Death Differ. 2014. PMID: 23787994 Free PMC article. Review.
Cyclophosphamide induces type I interferon and augments the number of CD44(hi) T lymphocytes in mice: implications for strategies of chemoimmunotherapy of cancer.
Schiavoni G, Mattei F, Di Pucchio T, Santini SM, Bracci L, Belardelli F, Proietti E. Schiavoni G, et al. Among authors: bracci l. Blood. 2000 Mar 15;95(6):2024-30. Blood. 2000. PMID: 10706870
Type I IFN as a natural adjuvant for a protective immune response: lessons from the influenza vaccine model.
Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, Venditti M, Capone I, Seif I, De Maeyer E, Tough D, Donatelli I, Belardelli F. Proietti E, et al. Among authors: bracci l. J Immunol. 2002 Jul 1;169(1):375-83. doi: 10.4049/jimmunol.169.1.375. J Immunol. 2002. PMID: 12077267
Type I IFN as a vaccine adjuvant for both systemic and mucosal vaccination against influenza virus.
Bracci L, Canini I, Venditti M, Spada M, Puzelli S, Donatelli I, Belardelli F, Proietti E. Bracci L, et al. Vaccine. 2006 Apr 12;24 Suppl 2:S2-56-7. doi: 10.1016/j.vaccine.2005.01.121. Vaccine. 2006. PMID: 16823927
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration.
Bracci L, Moschella F, Sestili P, La Sorsa V, Valentini M, Canini I, Baccarini S, Maccari S, Ramoni C, Belardelli F, Proietti E. Bracci L, et al. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):644-53. doi: 10.1158/1078-0432.CCR-06-1209. Clin Cancer Res. 2007. PMID: 17255288
IFN-alpha and novel strategies of combination therapy for cancer.
Bracci L, Proietti E, Belardelli F. Bracci L, et al. Ann N Y Acad Sci. 2007 Sep;1112:256-68. doi: 10.1196/annals.1415.030. Epub 2007 Jun 13. Ann N Y Acad Sci. 2007. PMID: 17567945 Review.
Type I interferons as vaccine adjuvants against infectious diseases and cancer.
Bracci L, La Sorsa V, Belardelli F, Proietti E. Bracci L, et al. Expert Rev Vaccines. 2008 Apr;7(3):373-81. doi: 10.1586/14760584.7.3.373. Expert Rev Vaccines. 2008. PMID: 18393607 Review.
Chemotherapy enhances vaccine-induced antitumor immunity in melanoma patients.
Nisticò P, Capone I, Palermo B, Del Bello D, Ferraresi V, Moschella F, Aricò E, Valentini M, Bracci L, Cognetti F, Ciccarese M, Vercillo G, Roselli M, Fossile E, Tosti ME, Wang E, Marincola F, Imberti L, Catricalà C, Natali PG, Belardelli F, Proietti E. Nisticò P, et al. Among authors: bracci l. Int J Cancer. 2009 Jan 1;124(1):130-9. doi: 10.1002/ijc.23886. Int J Cancer. 2009. PMID: 18839429 Clinical Trial.
Type I IFN regulate DC turnover in vivo.
Mattei F, Bracci L, Tough DF, Belardelli F, Schiavoni G. Mattei F, et al. Among authors: bracci l. Eur J Immunol. 2009 Jul;39(7):1807-18. doi: 10.1002/eji.200939233. Eur J Immunol. 2009. PMID: 19544312
Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis.
Schiavoni G, Sistigu A, Valentini M, Mattei F, Sestili P, Spadaro F, Sanchez M, Lorenzi S, D'Urso MT, Belardelli F, Gabriele L, Proietti E, Bracci L. Schiavoni G, et al. Among authors: bracci l. Cancer Res. 2011 Feb 1;71(3):768-78. doi: 10.1158/0008-5472.CAN-10-2788. Epub 2010 Dec 13. Cancer Res. 2011. PMID: 21156650
149 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback